Indica-G Inhalation Capsule 110 mcg+50 mcg is a dual bronchodilator therapy that combines Indacaterol (110 mcg), a long-acting beta-2 agonist (LABA), with Glycopyrronium (50 mcg), a long-acting muscarinic antagonist (LAMA). This combination is designed for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. By targeting two different mechanisms of airway relaxation, Indica-G provides sustained bronchodilation, improves lung function, and enhances quality of life in patients with moderate to severe COPD.

COPD is a progressive lung disease characterized by airflow limitation, chronic bronchitis, and emphysema, resulting in shortness of breath, chronic cough, and reduced exercise capacity. Indica-G Inhalation Capsules help relieve these symptoms, reduce exacerbations, and improve daily functioning.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each inhalation capsule contains:

• Indacaterol 110 mcg – a long-acting beta-2 adrenergic receptor agonist

• Glycopyrronium 50 mcg – a long-acting muscarinic receptor antagonist

These active ingredients work synergistically to relax airway muscles, improve airflow, and reduce hyperinflation.

Mechanism of Action

Indica-G combines two complementary bronchodilator mechanisms:

• Indacaterol (LABA): Stimulates beta-2 adrenergic receptors in the airway smooth muscle, causing relaxation and bronchodilation. This helps improve airflow, reduce breathlessness, and maintain lung function over 24 hours.

• Glycopyrronium (LAMA): Blocks muscarinic M3 receptors in the airway smooth muscle, inhibiting acetylcholine-mediated bronchoconstriction. This results in sustained airway relaxation and reduced mucus secretion.

The combination of LABA and LAMA provides superior bronchodilation compared to either agent alone, with additive benefits for lung function, exercise tolerance, and symptom control.

Indications

Indica-G Inhalation Capsule 110 mcg+50 mcg is indicated for:

• Maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults

• Reducing symptoms such as breathlessness, wheezing, and cough

• Improving exercise tolerance and daily activity in moderate to severe COPD

• Prevention of COPD exacerbations

Benefits

• Provides 24-hour sustained bronchodilation for symptom relief

• Reduces frequency of COPD exacerbations

• Improves lung function (FEV1) and quality of life

• Dual mechanism targets multiple pathways of airway obstruction

• Convenient inhalation capsule formulation for precise dosing

Dosage and Administration

• Recommended dose: 1 capsule inhaled once daily using a suitable dry powder inhaler device

• Administration:

  • Pierce the capsule in the inhaler device as per instructions

  • Inhale the powder slowly and deeply until the capsule is empty

  • Do not swallow the capsule; it is for inhalation only

• Regular use is recommended even if symptoms are mild; do not use for acute relief of sudden breathlessness

Precautions

• Not for use in acute asthma attacks or COPD exacerbations

• Use with caution in patients with cardiovascular disorders, glaucoma, or prostatic hyperplasia

• Seek medical advice before use during pregnancy or breastfeeding

• Avoid abrupt discontinuation; follow a healthcare professional’s guidance

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Indica-G Inhalation Capsules are generally well tolerated. Common side effects may include:

• Cough or throat irritation

• Dry mouth

• Headache or dizziness

• Palpitations or mild tremors (rare)

• Rare urinary retention or eye discomfort in sensitive individuals

Consult a physician if severe or persistent side effects occur.

Storage

Store below 30°C in a cool, dry place. Protect capsules from moisture and light. Keep out of reach of children.

Indica-G Inhalation Capsule 110 mcg+50 mcg offers a safe and effective maintenance therapy for COPD, providing sustained bronchodilation, improved lung function, and better daily life for patients under proper medical supervision.